Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Science Valley Wachstumsfonds is an early-stage venture capital fund based in Göttingen, Germany, dedicated to supporting scientific startups in the life sciences sector. Established in December 2022 with an initial volume of €12 million, the fund is backed by key regional partners including Sartorius AG, the State of Lower Saxony (via NBank), and the University Medical Center Göttingen (UMG). It targets early-stage (primarily seed) investments in Lower Saxony-based startups across biotechnology, medical technology, digital health, data science, and drug development. The fund is managed by Life Science Valley Ventures Management GmbH, led by Marco Janezic and Dr. Sven Wagner, providing both capital and strategic venture-building support to its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Life Science Valley Wachstumsfonds.